Target intelligence / Profile preview

Mycobacterial cell membrane

Molecular classification
Other
01

Overview

The mycobacterial cell membrane is a vital component of the complex cell envelope that distinguishes the genus Mycobacterium, including Mycobacterium tuberculosis. It consists of a standard inner plasma membrane and a unique, highly impermeable outer membrane known as the mycomembrane, which is characterized by a high concentration of long-chain mycolic acids (Source [9]). This membrane system is essential for maintaining the bacterial proton motive force, managing nutrient and waste transport, and providing a defensive barrier against host immune responses and antibiotic penetration (Source [1, 2, 9]). Drugs targeting the mycobacterial cell membrane function, most notably the first-line antibiotic pyrazinamide, work by dissipating the transmembrane pH gradient or disrupting the proton motive force, particularly in the acidic environments of host macrophages (Source [10, 11]). Other therapeutic agents target specific membrane-bound proteins, such as the MmpL3 transporter (inhibited by SQ109) and ATP synthase (inhibited by bedaquiline), to lethal effect by disrupting structural integrity or energy production (Source [1, 2, 5]). Because of its unique lipid composition, the mycobacterial membrane offers significant opportunities for the development of selective anti-tubercular agents that can eradicate both actively dividing and non-replicating persister bacilli (Source [2, 6]).

Other names
Mycobacterial membraneMycomembraneMycobacterial cell envelopeMycobacterial plasma membraneMycobacterial cell membrane function
02

Mechanism of action

Disruption of the transmembrane pH gradient and proton motive force, inhibition of membrane-bound transporters such as MmpL3, and interference with membrane-associated energy production like ATP synthesis (Source [1, 2, 10]).

03

Biological functions

Cellular barrierEnergy transductionNutrient transportStructural integrityPermeability
04

Disease associations

Infection
05

Safety considerations

Hepatotoxicity (Pyrazinamide) [10]Hyperuricemia (Pyrazinamide) [10]QT prolongation (Bedaquiline) [8]Increased mortality risk (Bedaquiline) [4]Potential for off-target mammalian membrane toxicity [6]
06

Interacting drugs

Pyrazinamide

5 more in the full profile.

07

Biomarkers

pncA gene mutationsatpE gene mutationsmmpL3 gene mutationsqcrB gene mutations

Beyond the preview

Go deeper on Mycobacterial cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call